Dr. Tage Honore

Dr. Tage Honore, President of Aestus Partners and a veteran in biotech and pharma, has driven over 40 drugs from concept to clinical development, including four prescription products. With 23 patents and expertise in neuropharmacology (DSc, University of Copenhagen), Dr. Honore provides strategic guidance to accelerate AmarnaBio’s therapeutic and commercial goals.